# Haimen Pharma Co., Ltd. – FDA Inspection, Jan 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/haimen-pharma-co-ltd/4a747ab0-b511-47c7-b5d1-105fe76954b7
Source feed: FDA_Inspections

> FDA inspection 1078088 of Haimen Pharma Co., Ltd., January 12, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1078088
- Company Name: Haimen Pharma Co., Ltd.
- Inspection Date: 2019-01-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- FDA Inspection 1254733 - 2023-08-25
- FDA Inspection 1115958 - 2020-01-10
- [FDA Inspection 1027385 - 2017-09-08](https://www.keypedia.com/records/fda_inspections/haimen-pharma-co-ltd/f95ae01e-dca4-45bf-8b8c-cd748a6c732e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)

Company: https://www.keypedia.com/companies/haimen-pharma-co-ltd/de674b77-14dd-4a89-a22f-20a4612af305

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8